Published ahead of print on July 19, 2007, doi:10.1164/rccm.200702-254OC
American Journal of Respiratory and Critical Care Medicine Vol 176. pp. 698-705, (2007)
© 2007 American Thoracic Society
doi: 10.1164/rccm.200702-254OC
Early Interstitial Lung Disease in Familial Pulmonary Fibrosis
Ivan O. Rosas1,
Ping Ren1,
Nilo A. Avila2,
Catherine K. Chow2,
Teri J. Franks3,
William D. Travis3,
J. Philip McCoy, Jr.4,
Rose M. May1,
Hai-Ping Wu1,
Dao M. Nguyen5,
Mauricio Arcos-Burgos6,
Sandra D. MacDonald1 and
Bernadette R. Gochuico1
1 Pulmonary–Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; 2 Diagnostic Radiology Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; 3 Department of Pulmonary and Mediastinal Pathology, Armed Forces Institute of Pathology, Washington, DC; 4 Flow Cytometry Core Facility, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; 5 Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and 6 Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland
Correspondence and requests for reprints should be addressed to Bernadette R. Gochuico, M.D., Pulmonary–Critical Care Medicine Branch, 10 Center Drive, MSC 1590, Bethesda, MD 20892-1590. E-mail: gochuicb{at}mail.nih.gov
Rationale: Identification of early, asymptomatic interstitial lung disease (ILD) in populations at risk of developing idiopathic pulmonary fibrosis (IPF) may improve the understanding of the natural history of IPF.
Objectives: To determine clinical, radiographic, physiologic, and pathologic features of asymptomatic ILD in family members of patients with familial IPF.
Methods: One hundred sixty-four subjects from 18 kindreds affected with familial IPF were evaluated for ILD. Bronchoalveolar lavage fluid cells were analyzed using flow cytometry. Lung biopsies were performed in six subjects with asymptomatic ILD.
Measurements and Main Results: High-resolution computed tomography abnormalities suggesting ILD were identified in 31 (22%) of 143 asymptomatic subjects. Subjects with asymptomatic ILD were significantly younger than subjects with known familial IPF (P < 0.001) and significantly older than related subjects without lung disease (P < 0.001). A history of smoking was identified in 45% of subjects with asymptomatic ILD and in 67% of subjects with familial IPF; these percentages were significantly higher than that of related subjects without lung disease (23%) (P = 0.02 and P < 0.001, respectively). Percentages of activated CD4+ lymphocytes were significantly higher in bronchoalveolar lavage fluid cells from subjects with asymptomatic ILD compared with related subjects without lung disease (P < 0.001). Lung biopsies performed in subjects with asymptomatic ILD revealed diverse histologic subtypes.
Conclusions: Asymptomatic ILD in individuals at risk of developing familial IPF can be identified using high-resolution computed tomography scan of the chest, especially in those with a history of smoking. Lung biopsies from individuals in this cohort with early asymptomatic lung disease demonstrate various histologic subtypes of ILD.
Key Words: idiopathic pulmonary fibrosis interstitial lung disease high-resolution computed tomography bronchoalveolar lavage asymptomatic interstitial lung disease
| AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
Despite significant progress in understanding the mechanisms involved in lung fibrosis, the natural history of the disease is still not well understood. There is evidence that a period of asymptomatic disease may precede the clinical diagnosis of interstitial lung disease (ILD).
What This Study Adds to the Field
A study on familial interstitial pneumonia demonstrated that some subjects without symptoms of lung disease had high-resolution computed tomography scan findings of ILD. Lung biopsies performed in subjects with familial interstitial pneumonia within the same family showed heterogeneous types of ILD.
|
This article has been cited by other articles:

|
 |

|
 |
 
S. R. Duncan
What Is Autoimmunity and Why Is It Likely to Be Important in Chronic Lung Disease?
Am. J. Respir. Crit. Care Med.,
January 1, 2010;
181(1):
4 - 5.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Cottin, J. Le Pavec, G. Prevot, H. Mal, M. Humbert, G. Simonneau, J-F. Cordier, and GERM"O"P
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
Eur. Respir. J.,
January 1, 2010;
35(1):
105 - 111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. N. Rouhani, M. L. Brantly, T. C. Markello, A. Helip-Wooley, K. O'Brien, R. Hess, M. Huizing, W. A. Gahl, and B. R. Gochuico
Alveolar Macrophage Dysregulation in Hermansky-Pudlak Syndrome Type 1
Am. J. Respir. Crit. Care Med.,
December 1, 2009;
180(11):
1114 - 1121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Lederer, P. L. Enright, S. M. Kawut, E. A. Hoffman, G. Hunninghake, E. J. R. van Beek, J. H. M. Austin, R. Jiang, G. S. Lovasi, and R. G. Barr
Cigarette Smoking Is Associated with Subclinical Parenchymal Lung Disease: The Multi-Ethnic Study of Atherosclerosis (MESA)-Lung Study
Am. J. Respir. Crit. Care Med.,
September 1, 2009;
180(5):
407 - 414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Xue and S. R. Duncan
Are Telomere Lengths of Leukocytes from Patients with Pulmonary Fibrosis Really Genetically Determined?
Am. J. Respir. Crit. Care Med.,
May 1, 2009;
179(9):
852 - 852.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Lynch III
Idiopathic Pulmonary Fibrosis, Nonspecific Interstitial Pneumonia/Fibrosis, and Sarcoidosis
ACCP Pulmonary Med Brd Rev,
January 1, 2009;
25(0):
635 - 686.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Cronkhite, C. Xing, G. Raghu, K. M. Chin, F. Torres, R. L. Rosenblatt, and C. K. Garcia
Telomere Shortening in Familial and Sporadic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
October 1, 2008;
178(7):
729 - 737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Wilkes
Clinical Year in Review III: Idiopathic Pulmonary Fibrosis, Occupational Medicine, and Lung Transplantation
Proceedings of the ATS,
September 15, 2008;
5(7):
751 - 754.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Young, L. M. Nogee, B. Barnett, R. J. Panos, T. V. Colby, and G. H. Deutsch
Usual Interstitial Pneumonia in an Adolescent With ABCA3 Mutations
Chest,
July 1, 2008;
134(1):
192 - 195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Maher, A. U. Wells, and G. J. Laurent
From the authors
Eur. Respir. J.,
May 1, 2008;
31(5):
1142 - 1143.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. U. Wells and C. M. Hogaboam
Update in Diffuse Parenchymal Lung Disease 2007
Am. J. Respir. Crit. Care Med.,
March 15, 2008;
177(6):
580 - 584.
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 American Thoracic Society
|
|
|